Neonc Technologies Holdings, Inc. (NASDAQ: NTHI)

Sector: Healthcare Industry: Biotechnology CIK: 0001979414
P/B -14.90
P/E -14.80
P/S 2,121.24
Market Cap 176.06 Mn
ROIC (Qtr) 0.00
Div Yield % 0.00
Rev 1y % (Qtr) 0.00
Total Debt (Qtr) 5.08 Mn
Debt/Equity (Qtr) -0.43

About

Stock Price Chart

Analysis

Pros

  • Retained earnings of (97.23M) represent substantial 8.23x of equity (11.81M), indicating strong internal capital generation.

Cons

  • Cash position of 1.51M provides weak coverage of payables of 6.89M, which is 0.22x, indicating potential working capital stress and supplier relationship risks.
  • Tangible assets of 4.08M provide limited backing for working capital of (12.63M), which is -0.32x, suggesting increased operational risk in market downturns.
  • Other current assets of 1.45M provide weak coverage of payables of 6.89M, which is 0.21x, suggesting potential working capital stress in near term.
  • Other current liabilities of 3.93M exceed cash reserves of 1.51M by 2.60x, suggesting potential near-term liquidity pressure.

Peer Comparison

Companies in the Biotechnology
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 SMMT Summit Therapeutics Inc. 1,349.40 Bn -1,464.17 0.00 0.01 Bn
2 ONC BeOne Medicines Ltd. 437.43 Bn 6,381.20 87.97 1.90 Bn
3 VRTX Vertex Pharmaceuticals Inc / Ma 116.09 Bn 31.59 9.90 1.83 Bn
4 REGN Regeneron Pharmaceuticals, Inc. 78.10 Bn 17.06 5.48 2.71 Bn
5 ALNY Alnylam Pharmaceuticals, Inc. 55.87 Bn 1,282.42 17.40 3.21 Bn
6 ARGX Argenx Se 52.85 Bn 35.08 27,559.65 -
7 BNTC Benitec Biopharma Inc. 41.75 Bn -998.33 0.00 0.00 Bn
8 INSM INSMED Inc 37.80 Bn -31.93 84.56 0.74 Bn

Industry Comparisons

Current Valuation

Metric Value Industry Percentile
EV to Assets 0.00 12.31
EV to Cash from Ops. 0.00 23.25
EV to Debt 0.00 738.44
EV to EBIT 0.00 -9.16
EV to EBITDA 0.00 6.95
EV to Free Cash Flow [EV/FCF] 0.00 21.90
EV to Market Cap 0.00 65.67
EV to Revenue 0.00 227.32
Price to Book Value [P/B] -14.90 22.34
Price to Earnings [P/E] -14.80 -11.77

Dividend Metrics

Metric Value Industry Percentile
Dividend Coverage Ratio 0.00 -11.94
Dividend Payout Ratio % 0.00 0.16
Dividend per Basic Share 0.00 0.01
FCF Dividend Payout Ratio % 0.00 -0.14
Interest Coverage 0.00 841.00

Growth Metrics

Metric Value Industry Percentile
Capex Growth (1y) % 0.00 -27.13
Cash and Equivalents Growth (1y) % 0.00 734.65
Dividend Growth (1y) % 0.00 0.01
EBIAT Growth (1y) % 0.00 -46.93
EBITDA Growth (1y) % 0.00 -1.68
EBIT Growth (1y) % 0.00 -56.45
EBT Growth (1y) % 0.00 -12.70
EPS Growth (1y) % 0.00 -28.31
FCF Growth (1y) % 0.00 -31.90
Gross Profit Growth (1y) % 0.00 226.84

Liquidity Ratios

Metric Value Industry Percentile
Asset Utilization Ratio 0.00 0.14
Cash Payout Ratio 0.00 0.00
Cash Ratio 0.10 3.85
Current Ratio 0.19 7.27
Debt to Equity Ratio -0.43 0.40
Interest Cover Ratio 0.00 841.00
Times Interest Earned 0.00 841.00

Profitability

Metric Value Industry Percentile
EBITDA Margin % 0.00 -18,234.31
EBIT Margin % 0.00 -18,580.80
EBT Margin % 0.00 -19,488.74
Gross Margin % 0.00 -7.59
Net Profit Margin % 0.00 -19,439.22